Accurate Investment Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-108,743
Closed -$3.37M 275
2020
Q1
$3.37M Sell
108,743
-89,817
-45% -$3.06M 2.73% 11
2019
Q4
$7.38M Sell
198,560
-1,477
-0.7% -$52.6K 4.81% 1
2019
Q3
$6.82M Buy
200,037
+90,312
+82% +$3.28M 4.98% 1
2019
Q2
$4.51M Buy
109,725
+2,152
+2% +$85.5K 3.43% 10
2019
Q1
$4.33M Sell
107,573
-1,652
-2% -$66.2K 3.41% 8
2018
Q4
$4.52M Sell
109,225
-1,692
-2% -$70.2K 4.09% 3
2018
Q3
$4.64M Buy
110,917
+735
+0.7% +$28.3K 3.21% 4
2018
Q2
$3.79M Buy
110,182
+4,320
+4% +$148K 2.79% 16
2018
Q1
$3.56M Buy
105,862
+950
+0.9% +$32.7K 2.7% 18
2017
Q4
$3.6M Sell
104,912
-1,231
-1% -$42K 2.65% 14
2017
Q3
$3.6M Buy
106,143
+1,654
+2% +$53.2K 2.71% 17
2017
Q2
$3.33M Buy
104,489
+3,024
+3% +$95.4K 2.74% 20
2017
Q1
$3.29M Buy
101,465
+9,234
+10% +$291K 2.66% 22
2016
Q4
$2.84M Buy
92,231
+88,312
+2,253% +$2.7M 2.53% 23
2016
Q3
$126K Buy
3,919
+216
+6% +$7.22K 0.12% 69
2016
Q2
$124K Buy
3,703
+5
+0.1% +$160 0.13% 61
2016
Q1
$104K Buy
3,698
+40
+1% +$1.14K 0.1% 89
2015
Q4
$112K Buy
+3,658
New +$115K 0.1% 72

Other funds holding PFE

Accurate Investment Solutions's PFE Position: Q2 2020 in Review

Accurate Investment Solutions sold out of Pfizer (PFE) in Q2 2020, closing a stake of 108,743 shares — an estimated $3.37M sold.

Accurate Investment Solutions first reported a position in PFE in Q4 2015 and held it in 18 quarters. The position peaked at $7.38M in Q4 2019. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Accurate Investment Solutions reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 108,743 Pfizer shares in Q2 2020, an estimated $3.37M.
  • Accurate Investment Solutions first reported a position in Pfizer in Q4 2015 and held it in 18 quarters.
  • Accurate Investment Solutions's Pfizer position peaked at $7.38M in Q4 2019.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.